<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Metronidazole (topical): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Metronidazole (topical): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Metronidazole (topical): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12251" href="/d/html/12251.html" rel="external">see "Metronidazole (topical): Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="16018" href="/d/html/16018.html" rel="external">see "Metronidazole (topical): Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F8770975"><span class="drugH1">Brand Names: US</span>
<ul>
<li>MetroCream;</li>
<li>Metrogel;</li>
<li>MetroLotion;</li>
<li>Noritate;</li>
<li>Nuvessa;</li>
<li>Rosadan [DSC];</li>
<li>Vandazole</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52869245"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Flagyl;</li>
<li>Metrogel;</li>
<li>Nidagel;</li>
<li>Noritate</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F8771007"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antibiotic, Topical</li></ul></div>
<div class="block doa drugH1Div" id="F8771178"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f74ecf56-4df6-48d7-b60e-9165458d8fec">Bacterial vaginosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bacterial vaginosis:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b> Note:</b> Treatment is generally not warranted for patients who are asymptomatic (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">0.75% gel: <b>Intravaginal:</b> One applicatorful (5 g containing ~37.5 mg metronidazole) once daily at bedtime for 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-10838277','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-10838277','lexi-content-ref-Manu.1'])">Ref</a></span>). For suppressive therapy following retreatment in patients with multiple disease recurrences, give twice weekly for 3 to 6 months (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-16647911']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-16647911'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">1.3% gel (alternative agent): <b>Intravaginal:</b> One applicatorful (5 g containing ~65 mg metronidazole) as a single dose; administer at bedtime (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-26222750','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-26222750','lexi-content-ref-Manu.1'])">Ref</a></span>). <b>Note:</b> Some experts favor multiday regimens of other formulations because of uncertain comparative efficacy with the single-dose regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-26222750','lexi-content-ref-Sobel.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-26222750','lexi-content-ref-Sobel.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cc3a2a3a-842f-4019-92f3-0d78d87a74b9">Rosacea</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rosacea: </b></p>
<p style="text-indent:-2em;margin-left:4em;">0.75%: <b>Topical:</b> Apply and rub a thin film twice daily, morning and evening, to entire affected areas after washing.</p>
<p style="text-indent:-2em;margin-left:4em;">1%: <b>Topical: </b>Apply thin film to affected area once daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6e3b92da-fcc4-4d5d-89cd-a6cbd0a5ada5">Trichomoniasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Trichomoniasis (alternative agent): Note:</b> Intravaginal metronidazole is <b>not </b>recommended because it is less effective than oral therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">10% (Flagyl Cream [Canadian product]): <b>Intravaginal: </b>Insert one applicatorful (equal to metronidazole 500 mg) intravaginally once or twice daily for 10 or 20 consecutive days (even during menses).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990577"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987932"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;margin-left:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution in severe hepatic impairment.</p></div>
<div class="block doe drugH1Div" id="F8771179"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F51776142"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="16018" href="/d/html/16018.html" rel="external">see "Metronidazole (topical): Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f74ecf56-4df6-48d7-b60e-9165458d8fec">Bacterial vaginosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bacterial vaginosis:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Vaginal gel 0.75%: Adolescents: Intravaginal: One applicatorful (~37.5 mg metronidazole) intravaginally once daily at bedtime for 5 days</p>
<p style="text-indent:-2em;margin-left:4em;">Vaginal gel 1.3%: Children ≥12 years and Adolescents: Intravaginal: One applicatorful (~65 mg metronidazole) intravaginally once at bedtime as a single dose</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5950f083-18f2-4533-a0c2-4ce2eb75ba61">Periorificial dermatitis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Periorificial dermatitis:</b> Limited data available: Infants ≥6 months, Children, and Adolescents: Topical: 0.75% gel: Apply thin film once or twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-1430388','lexi-content-ref-7962733','lexi-content-ref-17052482']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-1430388','lexi-content-ref-7962733','lexi-content-ref-17052482'])">Ref</a></span>)</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F52729774"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F52729775"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution in severe hepatic impairment.</p></div>
<div class="block adr drugH1Div" id="F8771048"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">1% to 10:</p>
<p style="text-indent:-2em;margin-left:6em;">Cardiovascular: Hypertension (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Central nervous system: Headache (2%)</p>
<p style="text-indent:-2em;margin-left:6em;">Dermatologic: Erythema (≤6%), contact dermatitis (1% to 3%), burning sensation of skin (&lt;3%), exacerbation of acne rosacea (&lt;3%), pruritus (&lt;3%), skin irritation (&lt;3%), stinging of the skin (&lt;3%), xeroderma (≤2%)</p>
<p style="text-indent:-2em;margin-left:6em;">Genitourinary: Urinary tract infection (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Hypersensitivity: Local hypersensitivity reaction (3%)</p>
<p style="text-indent:-2em;margin-left:6em;">Infection: Influenza (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Respiratory: Upper respiratory tract infection (3%)</p>
<p style="text-indent:-2em;margin-left:4em;">Frequent not defined:</p>
<p style="text-indent:-2em;margin-left:6em;">Central nervous system: Metallic taste, numbness of extremities, tingling of extremities</p>
<p style="text-indent:-2em;margin-left:6em;">Gastrointestinal: Nausea</p>
<p style="text-indent:-2em;margin-left:6em;">Ophthalmic: Lacrimation</p>
<p style="text-indent:-2em;margin-left:4em;">&lt;1%, postmarketing, and/or case reports: Acne vulgaris, conjunctivitis, eye irritation, peripheral neuropathy, xerostomia</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Vaginal:</b></p>
<p style="text-indent:-2em;margin-left:4em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:6em;">Genitourinary: Vaginal discharge (12%)</p>
<p style="text-indent:-2em;margin-left:6em;">Infection: Fungal infection (12%)</p>
<p style="text-indent:-2em;margin-left:4em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:6em;">Central nervous system: Headache (2% to 7%), dizziness (2%)</p>
<p style="text-indent:-2em;margin-left:6em;">Dermatologic: Pruritus (6%), skin rash (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Gastrointestinal: Gastrointestinal distress (7%), abdominal pain (5%), nausea (≤4%), vomiting (≤4%), dysgeusia (2%), abdominal cramps (1%), decreased appetite (1%), diarrhea (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Genitourinary: Vulvovaginal candidiasis (6% to 10%), cervical candidiasis (≤10%), vaginitis (≤10%), vulvovaginal irritation (9%), pelvic pain (3%), dysmenorrhea (1% to 3%), vulvovaginal pruritus (2%), abnormal uterine bleeding (1%), mastalgia (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Hematologic &amp; oncologic: Abnormal white blood cell differential (2%)</p>
<p style="text-indent:-2em;margin-left:6em;">Infection: Infection (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Neuromuscular &amp; skeletal: Muscle cramps (1%)</p>
<p style="text-indent:-2em;margin-left:6em;">Respiratory: Pharyngitis (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">&lt;1%, postmarketing, and/or case reports: Acne vulgaris, anorexia, asthma, back pain, bloating, breast hypertrophy, constipation, dark urine, depression, diaphoresis, dyspepsia, dysuria, edema (labial), fatigue, flatulence, flu-like symptoms, gingivitis, heavy menstrual bleeding, hypersensitivity reaction, increased thirst, insomnia, lactation, leukorrhea, mucous membrane disease, pain, pyelonephritis, rhinitis, salpingitis, urinary frequency, urinary tract infection, urticaria, vomiting, xerostomia</p></div>
<div class="block coi drugH1Div" id="F8771034"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to metronidazole, parabens, or other ingredients of the formulation or other nitroimidazole derivatives; use of alcohol or propylene glycol during therapy and for up to 24 hours after therapy discontinuation (vaginal gel only); use of disulfiram within the past 2 weeks (vaginal gel only).</p>
<p style="text-indent:-2em;margin-left:2em;">Flagyl cream [Canadian product]: Additional contraindications: Active neurological disorders; history of blood dyscrasia, hypothyroidism or hypoadrenalism.</p>
<p style="text-indent:-2em;margin-left:2em;">Nidagel [Canadian product]: Additional contraindications: Use during the first trimester of pregnancy.</p></div>
<div class="block war drugH1Div" id="F8771035"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Carcinogenic: Possibly carcinogenic based on animal data. Unnecessary use should be avoided.</p>
<p style="text-indent:-2em;margin-left:4em;">• CNS effects: Aseptic meningitis, encephalopathy, seizures, and neuropathies (peripheral and optic) have been reported with systemic metronidazole, especially with increased doses and chronic treatment; peripheral neuropathy has also been reported with topical products; monitor and consider discontinuation of therapy if signs/symptoms occur. Use with caution in patients with CNS diseases. Discontinue immediately if abnormal neurologic signs develop.</p>
<p style="text-indent:-2em;margin-left:4em;">• Eye irritation: May cause tearing of the eye; avoid contact with the eyes. In the event of accidental contact, wash out immediately.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatic impairment: Use with caution in patients with severe liver impairment due to potential accumulation.</p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection. Approximately 6% to 10% of women treated with the vaginal gel developed <i>Candida</i> vaginitis during or immediately after treatment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Blood dyscrasias: Use with caution in patients with or history of blood dyscrasias.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Vaginal gel: Disulfiram-like reaction to ethanol has been reported with systemic metronidazole and may occur with the vaginal gel; consumption of alcoholic beverages during therapy with vaginal gel is contraindicated during and for up to 72 hours after therapy. Do not administer the vaginal gel to patients who have taken disulfiram within the past 2 weeks. Patients should avoid vaginal intercourse during treatment.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878748"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F8771215"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">MetroCream: 0.75% (45 g) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Noritate: 1% (60 g) [contains methylparaben, propylparaben, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Rosadan: 0.75% (45 g [DSC]) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.75% (45 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Metrogel: 1% (55 g [DSC], 60 g) [contains methylparaben, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Rosadan: 0.75% (45 g [DSC]) [contains edetate (edta) disodium, methylparaben, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.75% (45 g); 1% (55 g, 60 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, Vaginal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nuvessa: 1.3% (5 g) [contains benzyl alcohol, methylparaben, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Vandazole: 0.75% (70 g) [contains methylparaben, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.75% (70 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Rosadan: 0.75% [DSC] [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Rosadan: 0.75% [DSC] [contains edetate (edta) disodium, methylparaben, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">MetroLotion: 0.75% (59 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.75% (59 mL)</p></div>
<div class="block geq drugH1Div" id="F8770978"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F8771217"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (MetroCream External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per gram): $16.68</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (metroNIDAZOLE External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per gram): $1.90 - $12.22</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Noritate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $39.13</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Metrogel External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $7.53</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (metroNIDAZOLE External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per gram): $3.64 - $7.10</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $5.04</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (metroNIDAZOLE Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per gram): $2.18 - $2.28</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Nuvessa Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.3% (per gram): $48.73</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Vandazole Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per gram): $2.33</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (MetroLotion External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per mL): $14.62</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (metroNIDAZOLE External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.75% (per mL): $4.19 - $4.85</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52869246"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Noritate: 1% (45 g) [contains methylparaben, propylparaben, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, Vaginal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Flagyl: 10% (60 g) [contains methylparaben, propylparaben, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Metrogel: 0.75% (3 g, 60 g); 1% (3 g, 60 g) [contains edetate (edta) disodium, methylparaben, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, Vaginal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nidagel: 0.75% (70 g) [contains edetate (edta) disodium, methylparaben, propylene glycol, propylparaben]</p></div>
<div class="block adm drugH1Div" id="F8771200"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b> No disulfiram-like reactions have been reported after <b>topical</b> application, although metronidazole can be detected in the blood. Apply to clean, dry skin. Cosmetics may be used after application (wait at least 5 minutes after using lotion).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Intravaginal:</b> For vaginal use only. Applicator may be inserted in any comfortable position. Hold the applicator by the barrel, gently insert into the vagina as far as possible without causing discomfort. Press the plunger until it stops and withdraw the applicator. Patients should not use intravaginal products (eg, tampons, douches) or engage in vaginal intercourse for the duration of treatment. Discard applicator after single use or if applicator will be re-used, clean applicator with warm soapy water and rinse well.</p>
<p style="text-indent:-2em;margin-left:4em;">10% (Flagyl cream [Canadian product]): Do not use applicator after the 7th month of pregnancy.</p></div>
<div class="block admp drugH1Div" id="F52614375"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Intravaginal: Use only <b>vaginal gel</b> intravaginally; fill applicator with medication; insert the applicator high into the vagina and press the plunger to release the medication; clean the applicator with warm soapy water and rinse well. Do not apply to the eye</p>
<p style="text-indent:-2em;margin-left:2em;">Topical: For topical use only. Wash affected areas with a mild cleanser; then apply a thin film of drug to the affected area and rub in. Cosmetics may be used after application (wait at least 5 minutes after using lotion). Do not apply to the eye.</p></div>
<div class="block use drugH1Div" id="F8771026"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Bacterial vaginosis:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Vaginal gel 0.75%: Treatment of bacterial vaginosis.</p>
<p style="text-indent:-2em;margin-left:4em;">Vaginal gel 1.3%: Treatment of bacterial vaginosis in females ≥12 years of age.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Rosacea:</b> Topical: Treatment of inflammatory lesions and erythema of rosacea.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Trichomoniasis:</b> Flagyl cream [Canadian product]: Treatment of trichomoniasis in females. <b>Note:</b> Intravaginal metronidazole is <b>not</b> recommended because it is less effective than oral therapy (CDC [Workowski 2021]).</p></div>
<div class="block mst drugH1Div" id="F59037386"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:2em;">MetroNIDAZOLE may be confused with metFORMIN</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F8771053"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F8771054"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Alcohol (Ethyl): MetroNIDAZOLE (Topical) may enhance the adverse/toxic effect of Alcohol (Ethyl). A disulfiram-like reaction may occur.  Management: Warn patients and monitor for signs and symptoms of a disulfiram-like reaction if patients consume alcohol while using topical metronidazole. Some manufacturers of vaginal metronidazole products list alcohol use within 24 to 72 hours as a contraindication<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Disulfiram: MetroNIDAZOLE (Topical) may enhance the adverse/toxic effect of Disulfiram. In particular, the risk for CNS toxicities such as psychosis may be increased.  Management: Warn patients and monitor for the development of serious CNS toxicity if topical metronidazole is used in a patient taking disulfiram. Some manufacturers of vaginal metronidazole products list disulfiram use within 2 weeks as a contraindication.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Lopinavir: MetroNIDAZOLE (Topical) may enhance the adverse/toxic effect of Lopinavir. Specifically, the use of topical metronidazole with lopinavir/ritonavir solution (which contains 42% alcohol) may result in a disulfiram-like reaction. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tipranavir: MetroNIDAZOLE (Topical) may enhance the adverse/toxic effect of Tipranavir. <i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F8771030"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Metronidazole crosses the placenta and rapidly distributes into the fetal circulation following oral administration. The amount of metronidazole available systemically following topical application is less in comparison to oral doses. Most studies have not shown an increased risk of adverse events to the fetus following maternal use during pregnancy (CDC [Workowski 2021]).</p>
<p style="text-indent:0em;margin-top:2em;">Bacterial vaginosis has been associated with adverse pregnancy outcomes; current guidelines recommend metronidazole for the treatment of symptomatic bacterial vaginosis in pregnancy. Pregnant patients may be treated with any regimens approved for nonpregnant patients; however, use of the metronidazole 1.3% vaginal gel should be avoided (insufficient data for efficacy) (CDC [Workowski 2021]). When used for the treatment of inflammatory lesions and erythema of rosacea, topical antibiotics, including metronidazole, are considered compatible with pregnancy (Murase 2014).</p></div>
<div class="block brc drugH1Div" id="F9773196"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Metronidazole and its active hydroxyl metabolite are present in breast milk following oral administration at concentrations similar to the maternal plasma concentrations. However, systemic absorption is less following topical or vaginal application.</p>
<p style="text-indent:-2em;margin-left:2em;">The manufacturer warns of the risk of carcinogenicity in patients exposed to metronidazole based on animal studies; theoretically, this risk is also present in breastfeeding infants exposed to metronidazole via breast milk. Therefore, some manufacturers recommend a decision be made whether to discontinue breastfeeding or to discontinue the drug, considering the importance of treatment to the mother. Alternately, some manufacturers suggest breastfeeding be interrupted during maternal treatment for bacterial vaginosis. Milk can be expressed and discarded during treatment and for 48 hours after therapy ends; the infant can be fed stored breast milk or formula. When used for the treatment of inflammatory lesions and erythema of rosacea, topical antibiotics, including metronidazole, are considered compatible with breastfeeding (Murase 2014).</p></div>
<div class="block pha drugH1Div" id="F8771139"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">After diffusing into the organism, interacts with DNA to cause a loss of helical DNA structure and strand breakage resulting in inhibition of protein synthesis and cell death in susceptible organisms</p></div>
<div class="block phk drugH1Div" id="F8771141"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;">Absorption:</p>
<p style="text-indent:-2em;margin-left:4em;">Topical: Concentrations achieved systemically after application of the 1 g topical gel and cream are &lt;1% of those obtained after a 250 mg oral dose</p>
<p style="text-indent:-2em;margin-left:4em;">Vaginal gel: Concentrations achieved systemically after application of  5 g vaginal gel (containing either 37.5 mg or 65 mg metronidazole) are ~2 % of those obtained after a 500 mg oral dose</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F14190112"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Dumozol | Elyzol | Rozex</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Colpofilin | Dinestal | Epaq | Etronil | Flagyl | Metral | Metrocev | Metrodermic | Metronidazol | Metronidazol biocrom | Metronidazol biol | Metronidazol richet | Metronidazol vannier | Nalox | Noritate | Padet | Repligen | Roxederm | Rozex | Tricofin</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Acsacea | Nidazea | Rozex</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Rozex | Zidoval</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Flamyd</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Nidazea | Rosaced | Rozex</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Nidazol | Vagilen</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Flagyl | Metrosa | Trichomonacid</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Canderm | Colplen | Flagimax | Flagyl | Flanizol | Helmizol | Lafepe metronidazol | Metronidan | Metronidazol | Metronide | Metronil | Metronix | Metroval | Neo Metrodazol | Rozex | Trigian | Trinodazol</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Metronidazole zentiva | Nidazea | Perilox | Rosalox</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Avazol</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Geloderm | Konicasol | Medazol | Metrocream | Metrogel | Metronidazol | Metropast | Noritate | Rubrimet | Triozol</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Li fu | Mai fu xin | Ni mei xin | Noritate | Yin kang ning</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Colpotricin | Flagyl | Gynezol | Gynogel | Metronidazol | Metronidazol MK | Metrozin | Ovaswiss | Ovazol | Rozex | Trimeba</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Rosalox | Rozex</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Metrocreme | Metrogalen | Metrogel | Metrolotion | Metrosa | Rosiced | Rozex | Vagi Metro</span>;</li>
<li>
<span class="countryCode">(DK)</span> <span class="country">Denmark</span><span class="countrySeparator">: </span><span class="drugName">Metronidazol Alpharma</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Epaq | Metotrex | Metrocaps | Metrocidan | Metrogel | Metronidazol | Nor-Metrogel | Triam</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Etron | Etron nistatina | Flagyl | Flagyl v | Metronidazol | Metronidazol MK | Metropast | Rozex | Tricoxin</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Gravagin | Metrosa | Rosalox | Rozex</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Amrizole | Dermozol | Flagyl | Metrizol | Metron | Rosagel | Tricho | Tricho gel | Trico</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Metronidazol vinas | Rozex | Tricowas b | Zidoval</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Metrogyl</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Elyzol colgate | Flagyl | Rosazol | Rozex | Trikozol | Zidoval</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Rosiced | Rozacreme | Rozagel | Rozex</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Acea | Anabact | Metrogel | Metrosa | Metrotop | Metroxx | Neutratop | Noritate | Rosiced | Rozex | Zidoval | Zyomet</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Colpocin t | Emedal | Flagyl | Metrogyl | Robaz | Rosiced | Tricodazol</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Frotin | Gynoplix | Noritate | Rosamed | Rozex</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Rozamet</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Klion | Metrosa | Rozex</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Neovyl | Vagizol</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Anabact | Metrogel | Metrotop | Rozex</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Noritate | Rozex</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Largyl | Metrogyl | Metrogyl-v</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Deflamon | Flagyl | Metronidazolo same | Rosased | Rosiced | Rozex | Vagilen | Zidoval</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Flanizol | Metrazine | Metroza | NewFlageed</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Rozex</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Anamint | Metrogyl | Metrogyl-v</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Menima | Merogel | Metroaole | Noritate | Rosacare | Rozex | Trogel</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Dumozol | Elyzol | Rozex</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Cutidermine | Elyzol | Flagyl | Noritate | Rozex</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Metrosa | Rozex</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Rosaced | Rozex</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Efloran | Flazole | Gynogel | Metrogyl | Metrogyl den | Rosalox | Rozex</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Nidazol | Rozex | Zyrdol gyn</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Amiyodazol | Datrizol | Epaq | Flagenase | Flagyl | Flagyl v | Lagylan | Metrocream | Metrogel | Metronidazol | Milezzol | Ovazol-v | Retofar | Rozex</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Frotin | Metrogyl | Rozex</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Anamint gel</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Flagyl | Metronidazol | Metrosa | Nidazea | Rosiced | Rozex</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Flagyl | Metronidazol | Rosazol | Rozex | Zidoval</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Rozex | Zidoval</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Baczyl | Flagyl | Metrodil | Metronidazol | Rozex</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Anagyl | Metrogyl | Robaz</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Anabact | Gynogel | Merizole | Metni V | Nidabact | Novamet | Revomet</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Arilin | Arilin rapid | Metronidazol | Rozetic | Rozex</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Metrocream | Metrogel | Metrogel Vaginal | Metrolotion | Metronidazole vaginal | Noritate | Nuvessa | Rosadan | Vandazole | Vitazol</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Dumozol | Elyzol | Flagyl | Metroderme | Norstene | Rodermil | Roseless | Rosiced</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Flagesol | Ginabiot | Hecomidazol | Metrodermic | Metrosol | Metrosol n.f. | Rozex | Tricofin</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Flagicure | Metzol</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Flagyl</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Metrogyl | Metronidazole altfarm | Metronidazole Cipla | Metroseptol | Metrovagin | Metrovit | Metrozol | Metrozol Denta | Rosamet | Rozex | Trichopol | Trichosept</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Amrizole | Dumozol | Rozex</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Robaz | Rosazol | Rozex | Zidoval</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Rozex</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Rozamet | Rozex</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Rozex</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Elyzol | Robaz</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Protogyl | Vagilen</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Metronidazol | Roza</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Amyda | Clogel | Efucon | Free | Frotin | Fulikan | Ginetrichon | Huli | Mefudazole | Mefugel | Metrocide | Metrodin | Metrogel | Zocon</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Flagyl | Gravagin | Gynezol | Metrogyl | Metrozol | Mistol | Rozamet</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Metrogyl</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Colpofilin | Epaq | Filantol | Flagesol | Gel para Rosacea | Metrodermic | Metronidazol | Metronidazol efa | Metronidazol Lazar | Roxederm | Rozex | Viosol</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Flegyl | Menizol | Metren | Metronidazol | Metrovax | Rozex</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Metrogel Vaginal | Rozex</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Cornizole denta gel</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Metrogel v</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.1">
<a name="AAP.1"></a>American Academy of Pediatrics (AAP). In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. <i>Red Book: 2012 Report of the Committee on Infectious Diseases</i>. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Flagyl.1">
<a name="Flagyl.1"></a>Flagyl Cream (metronidazole) [product monograph]. Laval, Quebec, Canada: Sanofi-aventis Canada Inc; May 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278. doi:10.1542/peds.99.2.268<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1430388">
<a name="1430388"></a>Manders SM, Lucky AW. Perioral dermatitis in childhood. <i>J Am Acad Dermatol</i>. 1992;27:688-692.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/1430388/pubmed" id="1430388" target="_blank">1430388</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Galderma.1">
<a name="Galderma.1"></a>MetroCream (metronidazole) [prescribing information]. Fort Worth, TX: Galderma Laboratories L.P.; January 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Galderma.2">
<a name="Galderma.2"></a>Metrogel (metronidazole) [prescribing information]. Fort Worth, TX: Galderma Laboratories LP; March 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Medicis.1">
<a name="Medicis.1"></a>Metrogel vaginal (metronidazole) [prescribing information]. Scottsdale, AZ: Medicis; January 2012.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Galderma.3">
<a name="Galderma.3"></a>MetroLotion (metronidazole) [prescribing information]. Fort Worth, TX: Galderma Laboratories; February 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Valeant.1">
<a name="Valeant.1"></a>Metronidazole gel [prescribing information]. Bridgewater, NJ: Valeant; March 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Valeant.2">
<a name="Valeant.2"></a>Metronidazole vaginal gel [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; March 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7962733">
<a name="7962733"></a>Miller SR, Shalita AR. Topical metronidazole gel (0.75%) for the treatment of perioral dermatitis in children. <i>J Am Acad Dermatol</i>. 1994;31:847-848.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/7962733/pubmed" id="7962733" target="_blank">7962733</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24528911">
<a name="24528911"></a>Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. <i>J Am Acad Dermatol</i>. 2014;70(3):401.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/24528911/pubmed" id="24528911" target="_blank">24528911</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17052482">
<a name="17052482"></a>Nguyen V, Eichenfield LE. Periorificial dermatitis in children and adolescents. <i>J Am Acad Dermatol</i>. 2006;55:781-785.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/17052482/pubmed" id="17052482" target="_blank">17052482</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bausch.1">
<a name="Bausch.1"></a>Nidagel (metronidazole) [product monograph]. Laval, Quebec, Canada: Bausch Health, Canada Inc; August 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bausch.2">
<a name="Bausch.2"></a>Noritate (metronidazole) 1% cream [prescribing information]. Bridgewater, NJ: Bausch Health US, LLC; June 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Exeltis.1">
<a name="Exeltis.1"></a>Nuvessa (metronidazole) [prescribing information]. Florham Park, NJ: Exeltis USA Inc; April 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Medimetriks.1">
<a name="Medimetriks.1"></a>Rosadan cream (metronidazole) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals Inc; December 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Medimetriks.2">
<a name="Medimetriks.2"></a>Rosadan gel (metronidazole) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals Inc; June 2013.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15592270">
<a name="15592270"></a>Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. <i>Am J Obstet Gynecol</i>. 2004;191(6):1898-1906. doi:10.1016/j.ajog.2004.06.089<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/15592270/pubmed" id="15592270" target="_blank">15592270</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26222750">
<a name="26222750"></a>Schwebke JR, Marrazzo J, Beelen AP, Sobel JD. A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis. <i>Sex Transm Dis</i>. 2015;42(7):376-381. doi:10.1097/OLQ.0000000000000300<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/26222750/pubmed" id="26222750" target="_blank">26222750</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Sobel.1">
<a name="Sobel.1"></a>Sobel JD. Bacterial vaginosis: Initial treatment. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed November 4, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16647911">
<a name="16647911"></a>Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. <i>Am J Obstet Gynecol</i>. 2006;194(5):1283-1289. doi:10.1016/j.ajog.2005.11.041<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/16647911/pubmed" id="16647911" target="_blank">16647911</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10838277">
<a name="10838277"></a>Soper DE, Livengood C, Sheehan KL, et al. Safety and efficacy comparison of two dosing regimens of MetroGel-Vaginal(R) in the treatment of bacterial vaginosis: a multicenter, randomized, single-blind, parallel comparison. <i>Prim Care Update Ob Gyns</i>. 1998;5(4):150. doi:10.1016/s1068-607x(98)00032-8<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/10838277/pubmed" id="10838277" target="_blank">10838277</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Upsher.1">
<a name="Upsher.1"></a>Vandazole (metronidazole) [prescribing information]. Maple Grove, MN: Upsher-Smith Laboratories LLC; February 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34292926">
<a name="34292926"></a>Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. <i>MMWR Recomm Rep</i>. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/metronidazole-topical-drug-information/abstract-text/34292926/pubmed" id="34292926" target="_blank">34292926</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9590 Version 380.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
